Author:
Rodriguez-Torres Maribel,Yoshida Eric M.,Marcellin Patrick,Srinivasan Subasree,Purohit Vivek S.,Wang Cunshan,Hammond Jennifer L.
Subject
Hepatology,General Medicine
Reference13 articles.
1. Preclinical characterization of PF-00868554, a potent nonnucleoside inhibitor of the hepatitis C virus RNA-dependent RNA polymerase;Shi;Antimicrob Agents Chemother,2009
2. Antiviral activity of the hepatitis C virus polymerase inhibitor filibuvir administered as monotherapy in HCV genotype 1 infected patients;Wagner;Hepatology,2011
3. Jacobson I, Pockros PJ, Lalezari, J, Lawitz E, Rodriguez-Torres M, DeJesus E, Haas F, et al. Virologic response rates following 4 weeks of filibuvir in combination with pegylated interferon alfa-2a and ribavirin in chronically-infected HCV genotype-1 patients. Program and abstracts of the 45th Annual Meeting of the European Association for the Study of Liver (EASL); April 24-28, 2010; Vienna, Austria.
4. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. Available from: http://www.wma.net/en/30publications/ 10policies/b3/index.html (accessed January 17, 2013).
5. Characterization of resistance to the nonnucleoside NS5B inhibitor filibuvir in hepatitis C virus-infected patients;Troke;Antimicrob Agents Chemother,2012
Cited by
21 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献